PALERMO, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 3.408
AS - Asia 2.140
EU - Europa 1.494
SA - Sud America 327
AF - Africa 121
OC - Oceania 23
Totale 7.513
Nazione #
US - Stati Uniti d'America 3.311
SG - Singapore 722
CN - Cina 530
IT - Italia 451
HK - Hong Kong 375
BR - Brasile 254
DE - Germania 222
SE - Svezia 196
VN - Vietnam 187
FR - Francia 97
AT - Austria 86
GB - Regno Unito 86
FI - Finlandia 71
BG - Bulgaria 67
IN - India 54
JP - Giappone 53
RU - Federazione Russa 49
KR - Corea 47
CI - Costa d'Avorio 43
TR - Turchia 42
CA - Canada 41
PL - Polonia 39
NL - Olanda 38
MX - Messico 28
ES - Italia 25
AR - Argentina 24
BD - Bangladesh 24
AU - Australia 23
IQ - Iraq 20
MA - Marocco 16
SN - Senegal 16
ZA - Sudafrica 14
PK - Pakistan 13
IE - Irlanda 12
CH - Svizzera 11
UA - Ucraina 11
UZ - Uzbekistan 11
PE - Perù 10
VE - Venezuela 10
SA - Arabia Saudita 9
EC - Ecuador 7
EG - Egitto 7
ID - Indonesia 7
JM - Giamaica 7
KE - Kenya 7
PH - Filippine 7
AE - Emirati Arabi Uniti 6
LT - Lituania 6
PA - Panama 6
CL - Cile 5
CZ - Repubblica Ceca 5
DZ - Algeria 5
IL - Israele 5
NG - Nigeria 5
PY - Paraguay 5
TW - Taiwan 5
UY - Uruguay 5
CO - Colombia 4
GR - Grecia 4
JO - Giordania 4
MY - Malesia 4
BE - Belgio 3
BO - Bolivia 3
CR - Costa Rica 3
EE - Estonia 3
HU - Ungheria 3
NP - Nepal 3
AO - Angola 2
AZ - Azerbaigian 2
BB - Barbados 2
GE - Georgia 2
HN - Honduras 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LU - Lussemburgo 2
TN - Tunisia 2
BS - Bahamas 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GD - Grenada 1
GH - Ghana 1
GT - Guatemala 1
IM - Isola di Man 1
IS - Islanda 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MN - Mongolia 1
MT - Malta 1
NI - Nicaragua 1
NO - Norvegia 1
PT - Portogallo 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
YT - Mayotte 1
Totale 7.513
Città #
Dallas 466
Ashburn 418
Singapore 404
Hong Kong 374
San Jose 329
Santa Clara 234
Fairfield 173
Chandler 157
Shanghai 134
Woodbridge 116
Milan 102
Munich 101
New York 101
Boardman 84
Seattle 83
Houston 82
Los Angeles 81
Beijing 80
Vienna 77
Wilmington 73
Hefei 71
Frankfurt am Main 70
Sofia 67
Ho Chi Minh City 52
Florence 46
Seoul 46
Tokyo 46
Cambridge 45
Turku 45
Abidjan 43
Lauterbourg 43
Princeton 40
Council Bluffs 39
Pisa 38
Lawrence 34
Serra 29
Warsaw 29
Medford 27
Ann Arbor 25
Hanoi 25
Guangzhou 24
São Paulo 24
London 23
Lucca 21
Redondo Beach 21
Buffalo 19
Helsinki 18
Rome 18
Melbourne 17
Trieste 17
Bremen 16
Dakar 16
Istanbul 16
Mexico City 15
Ogden 14
Columbus 13
Paris 13
San Diego 13
Baghdad 12
Montreal 12
Baltimore 11
Chicago 11
Orem 11
Zurich 11
Boulder 10
Chennai 10
Fuzhou 10
Boston 9
Casablanca 9
Denver 9
Haiphong 9
La Spezia 9
Nuremberg 9
San Francisco 9
Stockholm 9
Tashkent 9
Toronto 9
Brooklyn 8
Dong Ket 8
Manchester 8
Montignoso 8
Amsterdam 7
Atlanta 7
Belo Horizonte 7
Da Nang 7
Des Moines 7
Johannesburg 7
Newcastle upon Tyne 7
Ottawa 7
Phoenix 7
Talas 7
Barcelona 6
City of London 6
Dublin 6
Hyderabad 6
Naples 6
Palaia 6
Rio de Janeiro 6
Brno 5
Cascina 5
Totale 5.189
Nome #
Clinical Correlates of Cerebral Amyloid Deposition in Parkinson's Disease Dementia: Evidence from a PET Study 269
Brain-Derived Neurotrophic Factor (BDNF) and Serotonin Transporter (SERT) in Platelets of Patients with Mild Huntington’s Disease: Relationships with Social Cognition Symptoms 264
α-Synuclein Heteromers in Red Blood Cells of Alzheimer's Disease and Lewy Body Dementia Patients 215
Antipsychotic drugs in Huntington's disease 184
Intestinal histomorphological and molecular alterations in patients with Parkinson's disease 168
Involvement of the Nigrostriatal Pathway in Patients With Idiopathic Normal Pressure Hydrocephalus and Parkinsonism 166
Different Clinical Contexts of Use of Blood Neurofilament Light Chain Protein in the Spectrum of Neurodegenerative Diseases 162
Dissecting the Interplay between Time of Dementia and Cognitive Profiles in Lewy Body Dementias 155
Prevalence and clinical correlates of comorbid anxiety and panic disorders in patients with Parkinson’s disease 154
Connected speech in progressive supranuclear palsy: a possible role in differential diagnosis 153
Advances in the pharmacotherapeutic management of dementia with Lewy bodies 150
Fluid Biomarkers in Alzheimer’s Disease and Other Neurodegenerative Disorders: Toward Integrative Diagnostic Frameworks and Tailored Treatments 150
The neuroinflammatory biomarker YKL-40 for neurodegenerative diseases: advances in development 149
Impact of COVID-19 pandemic on cognition in Parkinson's disease 147
Neurogenic orthostatic hypotension in Parkinson's disease: is there a role for locus coeruleus magnetic resonance imaging? 145
Brain Aβ load association and sexual dimorphism of plasma BACE1 concentrations in cognitively normal individuals at risk for AD 145
A frontline defense against neurodegenerative diseases:the development of early disease detection methods 144
Prevalence and impact of COVID-19 in Parkinson’s disease: evidence from a multi-center survey in Tuscany region 144
Levodopa and neuropathy risk in patients with Parkinson disease: Effect of COMT inhibition 142
A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease 140
Freezing of gait and dementia in parkinsonism: A retrospective case–control study 139
MiRNA-15b and miRNA-125b are associated with regional Aβ-PET and FDG-PET uptake in cognitively normal individuals with subjective memory complaints 138
Exploring the Distinct Effect of Age at Onset and Caudate Denervation on Cognitive Deficits in Early Parkinson's Disease 135
Progress regarding the context-of-use of tau as biomarker of Alzheimer's disease and other neurodegenerative diseases 135
Differential default mode network trajectories in asymptomatic individuals at risk for Alzheimer's disease 133
Negative DAT-SPECT in Old Onset Parkinson's Disease: An Additional Pitfall? 126
Future avenues for Alzheimer's disease detection and therapy: Liquid biopsy, intracellular signaling modulation, systems pharmacology drug discovery 125
Qualitative evaluation of the Rey-Osterrieth Complex Figure Test in patients with progressive supranuclear palsy 124
Prokineticin-2 Is Highly Expressed in Colonic Mucosa of Early Parkinson's Disease Patients 123
Botulinum toxin for the treatment of dystonia and pain in corticobasal syndrome 120
Understanding the Multiple Role of Mitochondria in Parkinson’s Disease and Related Disorders: Lesson From Genetics and Protein–Interaction Network 118
Theory of mind in Parkinson’s disease: evidences in drug-naïve patients and longitudinal effects of dopaminergic therapy 115
Supplementing Best Care with Specialized Rehabilitation Treatment in Parkinson’s Disease: A Retrospective Study by Different Expert Centers 114
Extended release levodopa at bedtime as a treatment for nocturiain Parkinson's disease: An open label study 114
β-Secretase1 biological markers for Alzheimer’s disease: state-of-art of validation and qualification 111
The role of synaptic biomarkers in the spectrum of neurodegenerative diseases 110
Dopamine transporter imaging, current status of a potential biomarker: A comprehensive review 110
Different Patterns of Locus Coeruleus MRI Alteration in Alzheimer’s and Dementia with Lewy Bodies 110
Dopamine Transporter, Age, and Motor Complications in Parkinson's Disease: A Clinical and Single-Photon Emission Computed Tomography Study 109
Age and sex impact plasma NFL and t-Tau trajectories in individuals with subjective memory complaints: a 3-year follow-up study 108
Mitochondrial Parkinsonism: A Practical Guide to Genes and Clinical Diagnosis 106
Diagnosis of hereditary ataxias: a real-world single center experience 106
Two cases of Huntington's disease unmasked by the COVID-19 pandemic 105
Aptamarker prediction of brain amyloid-β status in cognitively normal individuals at risk for Alzheimer’s disease 102
Statins in Parkinson's Disease: Influence on Motor Progression 100
Association of plasma YKL-40 with brain amyloid-β levels, memory performance, and sex in subjective memory complainers 95
Expanding Glucocerebrosidase Involvement in Neurodegeneration: D419H Mutation Causing Dementia with Lewy Bodies 93
Perampanel as a novel treatment for subcortical myoclonus in myoclonus-dystonia syndrome 92
Dominant VPS16 Pathogenic Variants: Not Only Isolated Dystonia 92
α-Synuclein in Parkinson's Disease: From Bench to Bedside 89
Family History in Parkinson's Disease: A National Cross-Sectional Study 87
Early Compensatory Mechanisms in LRRK2 Mutation Carriers 87
null 86
Molecular Imaging of the Dopamine Transporter 85
Early autonomic and cognitive dysfunction in PD, DLB and MSA: blurring the boundaries between α-synucleinopathies 83
Mild Cognitive Impairment in de novo Parkinson's Disease: Selective Attention Deficit as Early Sign of Neurocognitive Decay 82
Benign versus malignant Parkinson disease: the unexpected silver lining of motor complications 82
Blood-based systems biology biomarkers for next-generation clinical trials in Alzheimer’s disease 68
SLC25A46 mutations in patients with Parkinson's Disease and optic atrophy 62
Essential tremor and cognitive impairment: who, how, and why 58
Tardive Syndrome Associated With Tetrabenazine in Huntington Disease: A Case Report 52
Clues to Reshaping Anti-α-Synuclein Immunotherapy in Early Parkinson's Disease Patients 45
Biomarker-drug and liquid biopsy co-development for disease staging and targeted therapy: Cornerstones for Alzheimer’s precision medicine and pharmacology 22
Commentary: Development of the Blood-Based Alzheimer's Disease Liquid Biopsy 17
Totale 7.659
Categoria #
all - tutte 23.797
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.797


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202145 0 0 0 0 0 0 0 0 0 0 0 45
2021/2022344 8 7 5 13 59 47 10 13 30 22 27 103
2022/2023674 82 106 69 45 51 64 6 39 147 1 52 12
2023/2024557 45 49 45 32 73 140 29 12 5 8 49 70
2024/20252.261 23 70 51 111 158 206 184 102 255 331 325 445
2025/20262.996 228 372 458 310 291 187 418 165 165 300 96 6
Totale 7.659